Patients in England with a certain type of advanced breast cancer will not have access to a new drug comb, after it was given an initial no for NHS use.
A new drug combo has been made available to some patients with advanced breast cancer on the NHS in England.
New research suggests the genetic and molecular make-up of individual breast tumours holds clues to how a woman’s disease could progress.
Scientists have created the most comprehensive method yet to predict a woman’s risk of breast cancer, according to a study by Cancer Research UK.
Three tests designed to predict if breast cancer will come back after treatment have been recommended for use on the NHS.
Only around a fifth of women at higher risk of developing breast cancer think they need to take a drug proven to help prevent the disease.
Rachel, from East Sussex, shares how her sister Thekla’s breast cancer diagnosis has affected the family so far.